Abstract
BACKGROUND AND OBJECTIVES: Tuberculum sellae meningiomas (TSMs) can be resected through transcranial (TCA) or expanded endonasal approach (EEA). The objective of this study was to report TSMmanagement trends and outcomes in a large multicenter cohort. METHODS: This is a 40-site retrospective study using standard statistical methods. RESULTS: In 947 cases, TCA was used 66.4% and EEA 33.6%. The median maximum diameter was 2.5 cm for TCA and 2.1 cm for EEA (P < .0001). The median follow-up was 26 months. Gross total resection (GTR) was achieved in 70.2% and did not differ between EEA and TCA (P = .5395). Vision was the same or better in 87.5%. Vision improved in 73.0% of EEA patients with preoperative visual deficits compared with 57.1% of TCA patients (P < .0001). On multivariate analysis, a TCA (odds ratio [OR] 1.78, P = .0258) was associated with vision worsening, while GTR was protective (OR 0.37, P < .0001). GTR decreased with increased diameter (OR: 0.80 per cm, P = .0036) and preoperative visual deficits (OR 0.56, P = .0075). Mortality was 0.5%. Complications occurred in 23.9%. New unilateral or bilateral blindness occurred in 3.3% and 0.4%, respectively. The cerebrospinal fluid leak ratewas 17.3% for EEA and 2.2% for TCA (OR 9.1, P < .0001). The recurrence ratewas 10.9%(n = 103). Longer follow-up (OR 1.01 per month, P < .0001),World Health Organization II/III (OR 2.20, P = .0262), and GTR (OR: 0.33, P < .0001) were associated with recurrence. The recurrence rate after GTR was lower after EEA compared with TCA (OR 0.33, P = .0027). CONCLUSION: EEA for appropriately selected TSM may lead to better visual outcomes and decreased recurrence rates afterGTR, but cerebrospinal fluid leak rates are high, and longer follow-up is needed. Tumors were smaller in the EEA group, and follow-up was shorter, reflecting selection, and observation bias. Nevertheless, EEA may be superior to TCA for appropriately selected TSM.
Original language | English (US) |
---|---|
Pages (from-to) | 1259-1270 |
Number of pages | 12 |
Journal | Neurosurgery |
Volume | 93 |
Issue number | 6 |
DOIs | |
State | Published - Dec 1 2023 |
Funding
Stephen T. Magill is supported by the Northwestern Medicine Malnati Brain Tumor institute of the Lurie Cancer Center. Paul A. Gardner has consulting agreements with SPIWay and Lazic. Daniel M. Prevedello is a consultant for BK Medical, Stryker Corp, Medtronic Corp and Integra LifeSciences Corp., has equity on 3 rivers LLC, and Soliton LLC, and receives royalties from KLS-Martin, ACE Medical and Mizuho. Michael W. McDermott is a consultant and has stock options with Deinde. The members of The International Tuberculum Sellae Meningioma project group have the following disclosures: Adam N. Mamelak has equity ownership and is a paid consultant to Blaze Bioscience, Seattle, WA; Ricardo L. Carrau is a consultant for Medtronic Corp. Michael R. Chicoine received funding from 1) IMRIS Inc. for an unrestricted educational grant to support an iMRI database and outcomes analysis project, the IMRIS Muliticenter intraoperative MRI Neurosurgery Database (I-MiND), 2) The Head for the Cure Foundation, and 3) Mrs. Carol Rossfeld and The Alex & Alice Aboussie Family Charitable Foundation. I-MiND is maintained in The REDCap server at Washington University in St. Louis is Supported by Clinical and Translational Science Award (CTSA) Grant [UL1 TR000448] and The Siteman Comprehensive Cancer Center and NCI Cancer Center Support Grant P30 CA091842. The project was supported by the UCSF Wolfe Meningioma Program Project.
Keywords
- Complications
- Endoscopic
- Expanded endonasal approach
- Meningioma
- Skull base
- Transsphenoidal
- Tuberculum
ASJC Scopus subject areas
- Surgery
- Clinical Neurology